Wyeth Signs Clinical Trial Partnership With Japan's Largest Hospital Network
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Wyeth's fully owned Japanese subsidiary signed a clinical trial partnership agreement with National Hospital Organization, the Japanese government body that manages most national hospitals, becoming the first pharmaceutical maker clinching such an accord with the largest hospital network in the country, Wyeth K.K. spokesman Ken Takashima said July 7
You may also be interested in...
Eisai Plans R&D Structure Revamp, Hoping To Turn The Development Tide
TOKYO - Eisai CEO Haruo Naito unveiled plans to revamp the company's research and development structure in hopes of having his employees produce better results, Naito told analysts Feb. 27 in Tokyo
Japanese Pharma Looking Beyond Japan For Clinical Trials
TOKYO - Japanese pharmaceutical manufacturers are diversifying their Phase III clinical trials away from Japan to establish development footholds into fast-developing East Asia and other regions where costs are low and trial patients can be secured with ease
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).